From DCAT Value Chain Insights (VCI)
Sanofi has appointed Yong-Jun Liu as head of research, global R&D, effective April 1, 2016. He will report to Dr. Elias Zerhouni, president, global R&D.
Dr. Liu will be responsible for leading all of Sanofi's research and will work in collaboration with Sanofi's senior leadership team to build a competitive R&D organization that leverages the best expertise, both internally and externally.
Dr. Liu has 25 years of experience in the pharmaceutical industry and at leading medical research centers. From 1991 to 1997, he was a senior and then principal scientist at Schering-Plough's Laboratory for Immunological Research. Dr. Liu held a principal staff scientist position at the DNAX Research Institute in California until 2002, when he became the founding director of the Cancer Immunology Research Institute at the University of Texas MD Anderson Cancer Center. At MD Anderson, he also served as the chair of the Department of Immunology. In 2011, Dr. Liu joined the Baylor Research Institute as vice president and chief scientific officer as well as director of the Baylor Institute for Immunology Research. He was appointed head of research at MedImmune in January 2014.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription